Mesoblast Limited
MEOBF
$1.55
-$0.04-2.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.67M | 25.67M | 7.02M | 7.02M | 1.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.67M | 25.67M | 7.02M | 7.02M | 1.58M |
| Cost of Revenue | 26.88M | 26.88M | 23.25M | 23.25M | 2.54M |
| Gross Profit | -1.21M | -1.21M | -16.23M | -16.23M | -964.50K |
| SG&A Expenses | 14.27M | 14.27M | 11.06M | 11.06M | 9.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.32M | -1.32M | 176.00K | 176.00K | 21.50K |
| Total Operating Expenses | 39.83M | 39.83M | 28.25M | 28.25M | 11.57M |
| Operating Income | -14.16M | -14.16M | -21.23M | -21.23M | -9.99M |
| Income Before Tax | -19.86M | -19.86M | -27.05M | -27.05M | -23.86M |
| Income Tax Expenses | 222.50K | 222.50K | 59.00K | 59.00K | 106.00K |
| Earnings from Continuing Operations | -20.08M | -20.08M | -27.10M | -27.10M | -23.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.08M | -20.08M | -27.10M | -27.10M | -23.97M |
| EBIT | -14.16M | -14.16M | -21.23M | -21.23M | -9.99M |
| EBITDA | -12.53M | -12.53M | -19.64M | -19.64M | -9.45M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.29B | 1.29B | 1.27B | 1.27B | 1.14B |
| Average Diluted Shares Outstanding | 1.29B | 1.29B | 1.27B | 1.27B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |